These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12782971)

  • 1. Multicentre Italian family-based association study on tyrosine hydroxylase, catechol-O-methyl transferase and Wolfram syndrome 1 polymorphisms in mood disorders.
    Serretti A; Cusin C; Cristina S; Lorenzi C; Lilli R; Lattuada E; Grieco G; Costa A; Santorelli F; Barale F; Smeraldi E; Nappi G
    Psychiatr Genet; 2003 Jun; 13(2):121-6. PubMed ID: 12782971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine hydroxylase gene in linkage disequilibrium with mood disorders.
    Serretti A; Macciardi F; Cusin C; Verga M; Pedrini S; Smeraldi E
    Mol Psychiatry; 1998 Mar; 3(2):169-74. PubMed ID: 9577842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol-O-methyltransferase gene variants in mood disorders in the Italian population.
    Serretti A; Rotondo A; Lorenzi C; Smeraldi E; Cassano GB
    Psychiatr Genet; 2006 Oct; 16(5):181-2. PubMed ID: 16969269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder.
    Rotondo A; Mazzanti C; Dell'Osso L; Rucci P; Sullivan P; Bouanani S; Gonnelli C; Goldman D; Cassano GB
    Am J Psychiatry; 2002 Jan; 159(1):23-9. PubMed ID: 11772685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders.
    Serretti A; Cristina S; Lilli R; Cusin C; Lattuada E; Lorenzi C; Corradi B; Grieco G; Costa A; Santorelli F; Barale F; Nappi G; Smeraldi E
    Am J Med Genet; 2002 May; 114(4):361-9. PubMed ID: 11992558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association of COMT Val158Met polymorphism with suicidal behavior or CSF monoamine metabolites in mood disorders.
    Zalsman G; Huang YY; Oquendo MA; Brent DA; Giner L; Haghighi F; Burke AK; Ellis SP; Currier D; Mann JJ
    Arch Suicide Res; 2008; 12(4):327-35. PubMed ID: 18828035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage between tyrosine hydroxylase gene and affective disorder cannot be excluded in two of six pedigrees.
    Lim LC; Gurling H; Curtis D; Brynjolfsson J; Petursson H; Gill M
    Am J Med Genet; 1993 Dec; 48(4):223-8. PubMed ID: 7907843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the COMT synonymous polymorphism Leu136Leu and missense variant Val158Met with mood disorders.
    Pandolfo G; Gugliandolo A; Gangemi C; Arrigo R; Currò M; La Ciura G; Muscatello MR; Bruno A; Zoccali R; Caccamo D
    J Affect Disord; 2015 May; 177():108-13. PubMed ID: 25766270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene.
    Kunugi H; Vallada HP; Hoda F; Kirov G; Gill M; Aitchison KJ; Ball D; Arranz MJ; Murray RM; Collier DA
    Biol Psychiatry; 1997 Aug; 42(4):282-5. PubMed ID: 9270905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families.
    Kunugi H; Vallada HP; Sham PC; Hoda F; Arranz MJ; Li T; Nanko S; Murray RM; McGuffin P; Owen M; Gill M; Collier DA
    Psychiatr Genet; 1997; 7(3):97-101. PubMed ID: 9323320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder.
    Serretti A; Macciardi F; Verga M; Cusin C; Pedrini S; Smeraldi E
    Am J Med Genet; 1998 Mar; 81(2):127-30. PubMed ID: 9613850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran.
    Yoshida K; Higuchi H; Takahashi H; Kamata M; Sato K; Inoue K; Suzuki T; Itoh K; Ozaki N
    Hum Psychopharmacol; 2008 Mar; 23(2):121-8. PubMed ID: 18023073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined analysis of association between personality traits and three functional polymorphisms in the tyrosine hydroxylase, monoamine oxidase A, and catechol-O-methyltransferase genes.
    Tochigi M; Otowa T; Hibino H; Kato C; Otani T; Umekage T; Utsumi T; Kato N; Sasaki T
    Neurosci Res; 2006 Mar; 54(3):180-5. PubMed ID: 16360899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare coding variant within the wolframin gene in bipolar and unipolar affective disorder cases.
    Furlong RA; Ho LW; Rubinsztein JS; Michael A; Walsh C; Paykel ES; Rubinsztein DC
    Neurosci Lett; 1999 Dec; 277(2):123-6. PubMed ID: 10624825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders.
    Mandelli L; Serretti A; Marino E; Pirovano A; Calati R; Colombo C
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):437-47. PubMed ID: 16756688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The WFS1 (Wolfram syndrome 1) is not a major susceptibility gene for the development of psychiatric disorders.
    Martorell L; Zaera MG; Valero J; Serrano D; Figuera L; Joven J; Labad A; Vilella E; Nunes V
    Psychiatr Genet; 2003 Mar; 13(1):29-32. PubMed ID: 12605098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of catechol-O-methyltransferase (COMT) functional polymorphism in bipolar affective disorder.
    Lachman HM; Kelsoe J; Moreno L; Katz S; Papolos DF
    Psychiatr Genet; 1997; 7(1):13-7. PubMed ID: 9264133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5.
    Kirov G; Jones I; McCandless F; Craddock N; Owen MJ
    Mol Psychiatry; 1999 Nov; 4(6):558-65. PubMed ID: 10578238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among north Indians.
    Srivastava V; Deshpande SN; Thelma BK
    Neuropsychobiology; 2010; 61(2):64-70. PubMed ID: 20016224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: a family-based study.
    Payton A; Holmes J; Barrett JH; Hever T; Fitzpatrick H; Trumper AL; Harrington R; McGuffin P; O'Donovan M; Owen M; Ollier W; Worthington J; Thapar A
    Am J Med Genet; 2001 Jul; 105(5):464-70. PubMed ID: 11449400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.